Direct and selective nanosensor for amyloid-β oligomers in serum for Alzheimer's disease diagnosis
Open Access
- 12 May 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (20) , 16175-16182
Abstract
The rising prevalence of Alzheimer's disease (AD) highlights an urgent need for ultra-sensitive diagnostic tools that facilitate early detection and intervention.Keywords
Funding Information
- Chinese University of Hong Kong
This publication has 16 references indexed in Scilit:
- A turn-on fluorescent immunosensor for neurodegenerative disease related neurofilament light chain proteinMicrochimica Acta, 2025
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluidNature Communications, 2024
- Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and futureSignal Transduction and Targeted Therapy, 2023
- Multifunctional theranostic carbazole-based cyanine for real-time imaging of amyloid-β and therapeutic treatment of multiple pathologies in Alzheimer's diseaseJournal of Materials Chemistry B, 2023
- Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometryScientific Reports, 2022
- Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer’s diseaseChemical Science, 2017
- The Need for Early Detection and Treatment in Alzheimer's DiseaseEBioMedicine, 2016
- Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosisActa Neuropathologica, 2015
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeuticsNature Reviews Drug Discovery, 2011